SYSTEMIC AND LOCAL IMMUNOMODULATORY EFFECTS OF INTRAVESICAL BCG THERAPY IN PATIENTS WITH SUPERFICIAL URINARY BLADDER CARCINOMAS
Data up to Jan 2025
Total Citations Per Year
Abstract
References (33)
Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors
1976 • 1,617 citations
Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors
2016 • 1,466 citations
Intracavitary bacillus Calmette-Grerin in the treatement of superficial bladder tumors
1976 • 978 citations
Effects of sleep and circadian rhythm on human circulating immune cells.
1997 • 584 citations
The potential biological and clinical significance of the soluble tumor necrosis factor receptors
1996 • 284 citations
Elevations of Cytokines Interleukin-1, Interleukin-2 and Tumor Necrosis Factor in the Urine of Patients after Intravesical Bacillus Calmette-Guerin Immunotherapy
1990 • 202 citations
Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer
1992 • 196 citations
Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance?
1997 • 172 citations
Detection of Interleukin 2 in the Urine of Patients with Superficial Bladder Tumors after Treatment with Intravesical BCG
1986 • 141 citations
Radio-Immunoassay Detection of Interferon-Gamma in Urine after Intravesical Evans BCG Therapy
1990 • 128 citations
Evaluation of a test system for measuring cytokine production in human whole blood cell cultures
1991 • 110 citations
Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin
1991 • 109 citations
BCG immunotherapy of bladder cancer: Inhibition of tumor recurrence and associated immune responses
1981 • 108 citations
Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer
1997 • 74 citations
INTERLEUKIN-8 EXPRESSION IN THE URINE AFTER BACILLUS CALMETTE-GUERIN THERAPY: A POTENTIAL PROGNOSTIC FACTOR OF TUMOR RECURRENCE AND PROGRESSION
1997 • 66 citations
Interleukin-2 production during intravesical bacille Calmette-Guerin therapy for bladder cancer
1986 • 63 citations
Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette–Guérin (BCG) in patients with superficial bladder cancer
1997 • 63 citations
The induction of bacillus-Calmette-Gu�rin-activated killer cells requires the presence of monocytes and T-helper type-1 cells
1995 • 59 citations
Localization of IL-1, IL-2, IL-4, IL-8 and TNF in Superficial Bladder Tumors Treated with Intravesical Bacillus Calmette-Guerin
1996 • 47 citations
Neutrophil-Activating Peptide-1/Interleukin-8 Detection in Human Urine during Acute Bladder Inflammation Caused by Transurethral Resection of Superficial Cancer and Bacillus Calmette-Guérin Administration
1991 • 46 citations
Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer.
1997 • 43 citations
Evolution and Clinical Significance of the T Cell Proliferative and Cytokine Response Directed Against the Fibronectin Binding Antigen 85 Complex of Bacillus Calmette-Guerin During Intravesical Treatment of Superficial Bladder Cancer
1997 • 36 citations
Evaluation of local immune response after intravesical bacille Calmette‐Guérin treatment for superficial bladder cancer
1996 • 33 citations
Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Guérin
1989 • 30 citations
Cytokine-mediated antitumor effect of bacillus Calmette-Gu�rin on tumor cells in vitro
1994 • 22 citations
Evaluation of Cellular Immunity following Bacillus Calmette-Guérin Therapy in Patients with Superficial Bladder Cancer
1995 • 19 citations
Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-Guerin.
1991 • 18 citations
Production of urinary tumour necrosis factors and soluble tumour necrosis factor receptors in bladder cancer patients afterbacillus Calmette-Guerin immunotherapy
1995 • 18 citations
Long-term immunobiological effects of intravesical bacillus Calmette-Guérin against bladder carcinoma recurrences.
1992 • 15 citations
Late Effects of Intravesical Bacillus Calmette-Guérin Immunotherapy on Bladder Mucosa Infiltrating Lymphocytes: An Immunohistochemical Study
1995 • 10 citations
Influence of Intravesical Bacillus Calmette‐Guerin Therapy on Systemic Immunological Status
1997 • 10 citations
Intravesical Bcg Therapy in Bladder Carcinoma: Effect on Cytotoxicity, IL-2 Production and Phenotype of Peripheral Blood Mononuclear Cells
1991 • 6 citations
Evolution of cellular and humoral response against Tuberculin and antigen 85 complex during intravesical treatment with BCG of superficial bladder cancer.
1994 • 6 citations